QI Program
The Northside Hospital blood and marrow transplant, leukemia, and immunotherapy quality management program: Why is it important?
Superior survival rates and high patient satisfaction have been attained thanks to our culture of ongoing process improvement, open communication, and patient care improvement. Our quality management program is centered on raising the standard of care for our patients.
The program satisfaction survey gives patients and their caregivers the chance to share what worked well and what needs to be improved. This comprehensive quality process enables the program to improve treatment protocols, supportive care algorithms, and patient management.
The Northside Hospital Blood and Marrow Transplant, Leukemia and Immunotherapy inpatient unit satisfaction survey results are consistently above the 95th percentile for physician care, nursing care and overall hospital experience. *
*According to the 2022 Press Ganey HCAHPS Regulatory Survey
Our quality management program consists of the following:
A peer reviewed quarterly quality assurance/improvement meeting
Corrective Action Plan(s) (process improvement) review
Bi-annual survival outcome meeting
Ashlee Holbein, BS, RN,FACT/QI Coordinator, Melissa Horowitz BS, RN, OCN, Manager of Cellular Therapy and Leukemia Program and Catherine Bastow, RN, FACT/QI Coordinator
Who is in charge of our QI program?
Dr. H. Kent Holland, our FACT program director, oversees the clinical transplant program’s quality management program.
NH-BMT has a designated FACT QI coordinator.
During the last six FACT inspection cycles, the clinical program has received outstanding commendations from each of the assigned FACT Inspectors, resulting in zero deficiencies during the 2003, 2006, 2009, 2012, 2015 and 2018 FACT Inspections.
BMT Program Quality External Audits: FACT
